Brazil's Azevêdo wins at the WTO: MSF calls for help on IP rules

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Brazil's Azevêdo wins at the WTO: MSF calls for help on IP rules

azevedo-45.jpg

A group campaigning for better access to medicines has urged the WTO’s incoming director-general to help ensure that least-developed countries remain exempt from implementing the TRIPs Agreement

Azevedo-WTO

Roberto Carvalho de Azevêdo, Brazil’s ambassador to the WTO, emerged yesterday as the trade body’s new director-general. He will take over from Pascal Lamy on September 1.

His recommendation by the heads of delegation to the WTO comes in the week that countries informally discuss a request by least-developed member states of the WTO to remain exempt from implementing TRIPs, ahead of the transition deadline in June. Médecins Sans Frontières says that if these countries are required to implement the WTO’s IP deal they will need to provide far higher levels of IP protection, which it says would see the cost of medicines and medical products in those countries soar.

Azevêdo’s new role will be challenging. The WTO has not concluded a trade deal for the past 20 years after failing to secure agreement on the Doha round of talks and member states have resorted to bilateral and regional deals to liberalise trade. These FTAs are typically concluded between rich countries or between rich countries and emerging economies.

Some have included so-called TRIPs-plus provisions, such as tougher rules on data exclusivity and extended patent terms than those mandated by TRIPs.

The Brazilian told the media in January that he had no clear plan for breaking the deadlock preventing a new multilateral agreement but that if elected to the WTO’s top job he would listen to delegates and try to understand the driving forces behind their negotiating positions.

He added that trade was simply a means to raise standards of living around the world rather than a goal in itself and that one of the key principles underpinning the WTO is that developing countries have to secure a commensurate share of trade according their needs.

“No country will open up trade if [the leader] believes it will sacrifice the living standards of his people in doing so,” he said. “That’s a political reality that will vary from country to country.”

The election of a candidate from an emerging country and the first WTO director-general to come from Latin America will be welcomed by those hoping that the organisation will give the concerns of developing countries more weight in trade discussions. But few are optimistic he will be able to unlocked stalled talks at the increasingly moribund organisation.

more from across site and SHARED ros bottom lb

More from across our site

The team, comprising two partners and one senior consultant, plans to offer “highly differentiated” services to clients
HGF’s new ownership model frees it from the hiring constraints of traditional partnerships, its CEO told Managing IP
New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Gift this article